Fig. 1From: Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challengesTCR structure A TCR-CD3 complex and ITAM. Cysteine (S) mediates interchain bridge of disulphide. B The natural TCR complex, CAR and four recombinant TCR complexesBack to article page